Regencell Bioscience Insider Trades
NASDAQ: RGCHealth Care Medicinal Chemicals and Botanical Products USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Regencell Bioscience insider activity
Over the last 12 months, Regencell Bioscience insiders reported 1 transaction on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows LO WILLIAM WING YAN DR (Director) reporting a transaction in 36,001 shares at $0.84 on Nov 17, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RGC's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
RGC insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 17, 2026 | LO WILLIAM WING YAN DRDirector | Option exercise | 36,001 | $30.24K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4